4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-20-000195
President-Protein Sciences sold 11,357 shares at an average $261.45 ($2,969,274)
- President-Protein Sciences acquired 11,357 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eansor Norman David President-Protein Sciences | 2020-05-28 | Option exercise | +3,448 | $108.49 | $374,074 | 3,448 | D: show line 1 in the form |
| Eansor Norman David President-Protein Sciences | 2020-05-28 | Sale | −3,448 | $260.19 | $897,134 | 0 | D: show line 2 in the form |
| Eansor Norman David President-Protein Sciences | 2020-05-29 | Option exercise | +7,909 | $108.49 | $858,047 | 7,909 | D: show line 3 in the form |
| Eansor Norman David President-Protein Sciences | 2020-05-29 | Sale | −1,700 | $260.83 | $443,410 | 6,209 | D: show line 4 in the form |
| Eansor Norman David President-Protein Sciences | 2020-05-29 | Sale | −3,400 | $261.74 | $889,927 | 2,809 | D: show line 5 in the form |
| Eansor Norman David President-Protein Sciences | 2020-05-29 | Sale | −2,100 | $262.68 | $551,619 | 709 | D: show line 6 in the form |
| Eansor Norman David President-Protein Sciences | 2020-05-29 | Sale | −709 | $264.01 | $187,184 | 0 | D: show line 7 in the form |
| Open-market sales · 11,357 sh · avg $261.45 · $2,969,274 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Eansor Norman David President-Protein Sciences | 2020-05-28 | Option exercise · Stock Options (Right to Buy) | −3,448 | 7,909 | D: show line 8 in the form | |||||
| Eansor Norman David President-Protein Sciences | 2020-05-29 | Option exercise · Stock Options (Right to Buy) | −7,909 | 0 | D: show line 9 in the form |
Loading xslF345X03/edgar.xml…